A good amount of good research has already shown that the bisphosphonate drugs claimed to prevent osteopenia and treat osteoporosis can cause bone death in the jaw – a condition known as osteonecrosis. Despite this, as well as the fact that
a study in the Archives of Internal Medicine this year found that Fosamax doubled women’s risk of irregular heartbeat, which can cause clots and strokes, few doubted its primary action of protecting women’s bones.
But now, like hormone replacement therapy, which also exploited women’s fear of aging and social marginalization, Fosamax appears to cause the conditions it’s supposed to prevent.
Since 2006, articles in the New England Journal of Medicine, Journal of Orthopedic Trauma, Journal of Bone and Joint Surgery, Journal of Clinical Endocrinology & Metabolism and Aging Clinical and Experimental Research have suggested the anti-bone turnover action of bisphosphonate drugs like Fosamax can in some cases cause fractures.
Oops.
Read all of Martha Rosenberg’s excellent AlterNet article on this matter: Big Pharma Pushes Drugs that Cause Conditions They Are Supposed to Prevent
